# L_2013261EN.01000501.xml

| 3.10.2013 | EN | Official Journal of the European Union | L 261/5 |
| --- | --- | --- | --- |

3.10.2013

EN

Official Journal of the European Union

L 261/5

---

COMMISSION REGULATION (EU) No 944/2013

of 2 October 2013

amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) and Article 53 thereof,

Whereas:

| (1) | In respect of precautionary statement P210 set out in table 6.2 Part 1 of Annex IV to Regulation (EC) No 1272/2008 the 5th revision of the Globally Harmonised System of Classification and Labelling of Chemicals (hereinafter ‘GHS’) of the United Nations has brought about changes which were not fully taken into account in Commission Regulation (EU) No 487/2013 (2). For reasons of consistency it is necessary to provide for full alignment between the GHS and Regulation (EC) No 1272/2008. |
| --- | --- |

(1)

In respect of precautionary statement P210 set out in table 6.2 Part 1 of Annex IV to Regulation (EC) No 1272/2008 the 5th revision of the Globally Harmonised System of Classification and Labelling of Chemicals (hereinafter ‘GHS’) of the United Nations has brought about changes which were not fully taken into account in Commission Regulation (EU) No 487/2013 (2). For reasons of consistency it is necessary to provide for full alignment between the GHS and Regulation (EC) No 1272/2008.

| (2) | Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (3). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications. |
| --- | --- |

(2)

Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (3). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications.

| (3) | The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances. |
| --- | --- |

(3)

The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances.

| (4) | The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (4). |
| --- | --- |

(4)

The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (4).

| (5) | With regard to the substance pitch, coal tar, high-temp. (EC Number: 266-028-2), an extended period of time will be necessary to allow operators to comply with the obligations resulting from the new harmonised classification for substances classified as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 3 and Annex III of Directive 2008/68/EC of the European Parliament and of the Council of 24 September 2008 on the inland transport of dangerous goods (5). Therefore, a longer transition time should be foreseen before the harmonised classification has to be applied. |
| --- | --- |

(5)

With regard to the substance pitch, coal tar, high-temp. (EC Number: 266-028-2), an extended period of time will be necessary to allow operators to comply with the obligations resulting from the new harmonised classification for substances classified as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 3 and Annex III of Directive 2008/68/EC of the European Parliament and of the Council of 24 September 2008 on the inland transport of dangerous goods (5). Therefore, a longer transition time should be foreseen before the harmonised classification has to be applied.

| (6) | With regard to the substance gallium arsenide (EC Number: 215-114-8), the RAC is in the process of adopting a new opinion for the hazard class ‘toxicity to reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised. |
| --- | --- |

(6)

With regard to the substance gallium arsenide (EC Number: 215-114-8), the RAC is in the process of adopting a new opinion for the hazard class ‘toxicity to reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised.

| (7) | With regard to the substance polyhexamethylene biguanide hydrochloride (CAS number 27083-27-8 or 32289-58-0), new scientific data has been made available for the hazard class ‘acute toxicity (inhalation)’, which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver an opinion on the new information, while all other hazard classes covered by the earlier RAC opinion should be included. |
| --- | --- |

(7)

With regard to the substance polyhexamethylene biguanide hydrochloride (CAS number 27083-27-8 or 32289-58-0), new scientific data has been made available for the hazard class ‘acute toxicity (inhalation)’, which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver an opinion on the new information, while all other hazard classes covered by the earlier RAC opinion should be included.

| (8) | In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before the dates by which the harmonised classifications will become mandatory. |
| --- | --- |

(8)

In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before the dates by which the harmonised classifications will become mandatory.

| (9) | The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006, |
| --- | --- |

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 1272/2008 is amended as follows:

| (1) | Annex IV is amended in accordance with the Annex I to this Regulation; |
| --- | --- |

(1)

Annex IV is amended in accordance with the Annex I to this Regulation;

| (2) | Part 3 of Annex VI is amended as follows:






  (a) | Table 3.1 is amended as follows:






  (i) | The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex II to this Regulation are replaced by the entries set out in Annex II to this Regulation; |
| --- | --- | --- | --- |

(2)

Part 3 of Annex VI is amended as follows:

(a)

Table 3.1 is amended as follows:

(i)

The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex II to this Regulation are replaced by the entries set out in Annex II to this Regulation;

| (ii) | The entries set out in Annex III to this Regulation are inserted in accordance with the order of the entries set out in Table 3.1. |
| --- | --- |

(ii)

The entries set out in Annex III to this Regulation are inserted in accordance with the order of the entries set out in Table 3.1.

| (b) | Table 3.2 is amended as follows:






  (i) | The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex IV to this Regulation are replaced by the entries set out in in Annex IV to this Regulation; |
| --- | --- | --- |

(b)

Table 3.2 is amended as follows:

(i)

The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex IV to this Regulation are replaced by the entries set out in in Annex IV to this Regulation;

| (ii) | The entries set out in Annex V to this Regulation are inserted in accordance with the order of the entries set out in Table 3.2. |
| --- | --- |

(ii)

The entries set out in Annex V to this Regulation are inserted in accordance with the order of the entries set out in Table 3.2.

Article 2

1.   By way of derogation from Article 3(2) substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation.

2.   By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 December 2016.

3.   By way of derogation from Article 3(2) mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 June 2017.

4.   By way of derogation from Article 3(3) the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, may be applied before the dates referred to in Article 3(3).

Article 3

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2.   Article 1(1) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.

3.   Article 1(2) shall apply from 1 January 2015 for all entries except for the entry pitch, coal tar, high-temp. (EC Number 266-028-2), for which Article 1 shall apply from 1 April 2016.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 2 October 2013.

For the Commission

The President

José Manuel BARROSO

---

(1)  
  OJ L 353, 31.12.2008, p. 1.

1

(2)  
  OJ L 149, 1.6.2013, p. 1.

2

(3)  
  OJ 196, 16.8.1967, p. 1.

3

(4)  
  OJ L 396, 30.12.2006, p. 1.

4

(5)  
  OJ L 260, 30.9.2008, p. 13.

5

(6)  
  OJ L 200, 30.7.1999, p. 1.

6

---

ANNEX I

In Part 1, Table 6.2 of Annex IV to Regulation (EC) No 1272/2008, Code P210 is replaced by the following:

| ‘P210 | Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. | Explosives (section 2.1) | Divisions 1.1, 1.2, 1.3, 1.4, 1.5 | |
| --- | --- | --- | --- | --- |
| Flammable gases (section 2.2) | 1, 2 |
| Aerosols (section 2.3) | 1, 2, 3 |
| Flammable liquids (section 2.6) | 1, 2, 3 |
| Flammable solids (section 2.7) | 1, 2 |
| Self-reactive substances and mixtures (section 2.8) | Types A, B, C, D, E, F |
| Pyrophoric liquids (section 2.9) | 1 |
| Pyrophoric solids (section 2.10) | 1 |
| Oxidising liquids (section 2.13) | 1, 2, 3 |
| Oxidising solids (section 2.14) | 1, 2, 3 |
| Organic peroxides (section 2.15) | Types A, B, C, D, E, F’ |

‘P210

Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.

Explosives (section 2.1)

Divisions 1.1, 1.2, 1.3, 1.4, 1.5

Flammable gases (section 2.2)

1, 2

Aerosols (section 2.3)

1, 2, 3

Flammable liquids (section 2.6)

1, 2, 3

Flammable solids (section 2.7)

1, 2

Self-reactive substances and mixtures (section 2.8)

Types A, B, C, D, E, F

Pyrophoric liquids (section 2.9)

1

Pyrophoric solids (section 2.10)

1

Oxidising liquids (section 2.13)

1, 2, 3

Oxidising solids (section 2.14)

1, 2, 3

Organic peroxides (section 2.15)

Types A, B, C, D, E, F’

---

ANNEX II

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits,
  M — Factors | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) |
| 015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Acute Tox. 1 | H330 | Dgr | H330 | |
| Aquatic Acute 1 | H400 | | H400 | |
| 015-005-00-3 | magnesium phosphide;
  trimagnesium diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Acute Tox. 1 | H330 | Dgr | H330 | |
| Aquatic Acute 1 | H400 | | H400 | |
| 015-123-00-5 | fenamiphos (ISO);
  ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | H300 | GHS06 | H300 | | M = 100
  M = 100 | |
| Acute Tox. 2 | H310 | GHS09 | H310 |
| Acute Tox. 2 | H330 | Dgr | H330 |
| Eye Irrit. 2 | H319 | | H319 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | | H413 | | | |
| 602-006-00-4 | chloroform;
  trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | H351 | GHS06 | H351 | | | |
| Repr. 2 | H361d | GHS08 | H361d |
| Acute Tox. 3 | H331 | Dgr | H331 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 | | H372 |
| Eye Irrit. 2 | H319 | | H319 |
| Skin Irrit. 2 | H315 | | H315 |
| 603-097-00-3 | 1,1’,1’-nitrilotripropan-2-ol;
  triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 605-008-00-3 | acrolein;
  prop-2-enal;
  acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | EUH071 | Skin Corr. 1; H314: C ≥ 0,1 % | D |
| Acute Tox. 1 | H330 | GHS06 | H330 | |
| Acute Tox. 2 | H300 | GHS05 | H300 | |
| Acute Tox. 3 | H311 | GHS09 | H311 | |
| Skin Corr. 1 | H314 | Dgr | H314 | |
| Aquatic Acute 1 | H400 | | | | M = 100 |
| Aquatic Chronic 1 | H410 | | H410 | | M = 1 |
| 607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Carc. 2 | H351 | GHS08 | H351 | | |
| Acute Tox. 4 | H332 | GHS07 | H332 | | |
| STOT SE 3 | H335 | Dgr | H335 | | |
| 607-613-00-8 | reaction mass of: | succinic acid |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Specific Conc. Limits,

M — Factors

Notes

Hazard Class and Category Code(s)

Hazard statement Code(s)

Pictogram, Signal Word Code(s)

Hazard statement Code(s)

Suppl. Hazard statement Code(s)

015-004-00-8

aluminium phosphide

244-088-0

20859-73-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Dgr

H330

Aquatic Acute 1

H400

H400

015-005-00-3

magnesium phosphide;

trimagnesium diphosphide

235-023-7

12057-74-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Dgr

H330

Aquatic Acute 1

H400

H400

015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-1

22224-92-6

Acute Tox. 2

H300

GHS06

H300

M = 100

M = 100

Acute Tox. 2

H310

GHS09

H310

Acute Tox. 2

H330

Dgr

H330

Eye Irrit. 2

H319

H319

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

Aquatic Chronic 4

H413

H413

602-006-00-4

chloroform;

trichloromethane

200-663-8

67-66-3

Carc. 2

H351

GHS06

H351

Repr. 2

H361d

GHS08

H361d

Acute Tox. 3

H331

Dgr

H331

Acute Tox. 4

H302

H302

STOT RE 1

H372

H372

Eye Irrit. 2

H319

H319

Skin Irrit. 2

H315

H315

603-097-00-3

1,1’,1’-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4

122-20-3

Eye Irrit. 2

H319

GHS07

Wng

H319

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4

107-02-8

Flam. Liq. 2

H225

GHS02

H225

EUH071

Skin Corr. 1; H314: C ≥ 0,1 %

D

Acute Tox. 1

H330

GHS06

H330

Acute Tox. 2

H300

GHS05

H300

Acute Tox. 3

H311

GHS09

H311

Skin Corr. 1

H314

Dgr

H314

Aquatic Acute 1

H400

M = 100

Aquatic Chronic 1

H410

H410

M = 1

607-023-00-0

vinyl acetate

203-545-4

108-05-4

Flam. Liq. 2

H225

GHS02

H225

D

Carc. 2

H351

GHS08

H351

Acute Tox. 4

H332

GHS07

H332

STOT SE 3

H335

Dgr

H335

607-613-00-8

reaction mass of:

succinic acid

| | monopersuccinic acid |
| --- | --- |

monopersuccinic acid

| | dipersuccinic acid |
| --- | --- |

dipersuccinic acid

| | monomethyl ester of succinic acid |
| --- | --- |

monomethyl ester of succinic acid

| | monomethyl ester of persuccinic acid |
| --- | --- |

monomethyl ester of persuccinic acid

| | dimethyl succinate glutaric acid |
| --- | --- |

dimethyl succinate glutaric acid

| | monoperglutaric acid |
| --- | --- |

monoperglutaric acid

| | diperglutaric acid |
| --- | --- |

diperglutaric acid

| | monomethyl ester of glutaric acid |
| --- | --- |

monomethyl ester of glutaric acid

| | monomethyl ester of perglutaric acid |
| --- | --- |

monomethyl ester of perglutaric acid

| | dimethyl glutarate adipic acid |
| --- | --- |

dimethyl glutarate adipic acid

| | monoperadipic acid |
| --- | --- |

monoperadipic acid

| | diperadipic acid |
| --- | --- |

diperadipic acid

| | monomethyl ester of adipic acid |
| --- | --- |

monomethyl ester of adipic acid

| | monomethyl ester of peradipic acid |
| --- | --- |

monomethyl ester of peradipic acid

| | dimethyl adipate |
| --- | --- |

dimethyl adipate

| | hydrogen peroxide |
| --- | --- |

hydrogen peroxide

| | methanol |
| --- | --- |

methanol

| | water |
| --- | --- |

water

432-790-1

Acute Tox. 4*

H332

GHS07

H332

Acute Tox. 4*

H312

GHS05

H312

Acute Tox. 4*

H302

GHS08

H302

Skin Corr. 1B

H314

Dgr

H314

STOT SE 2

H371 (eyes)

H371 (eyes)

609-003-00-7

nitrobenzene

202-716-0

98-95-3

Carc. 2.

H351

GHS06

H351

Repr. 1B

H360F

GHS08

H360F

Acute Tox. 3

H301

Dgr

H301

Acute Tox. 3

H331

H331

Acute Tox. 3

H311

H311

STOT RE 1

H372 (blood)

H372 (blood)

Aquatic Chronic 3

H412

H412

612-120-00-6

aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline

277-704-1

74070-46-5

Carc. 2

H351

GHS08

H351

M = 100

M = 10

Skin Sens. 1A

H317

GHS07

H317

Aquatic Acute 1

H400

GHS09

Aquatic Chronic 1

H410

Wng

H410

613-175-00-9

epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2

133855-98-8

Carc. 2

H351

GHS08

H351

Repr. 1B

H360Df

GHS09

H360Df

Aquatic Chronic 2

H411

Dgr

H411

616-200-00-1

reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)

432-430-3

Aquatic Chronic 4

H413

H413

648-055-00-5

pitch, coal tar, high-temp.;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-2

65996-93-2

Carc. 1A

H350

GHS08

H350

M = 1000

M = 1000

Muta. 1B

H340

GHS09

H340

Repr. 1B

H360FD

Dgr

H360FD

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

649-330-00-2

naphtha (petroleum), hydrodesulphurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-4

64742-82-1

Carc. 1B

H350

GHS08

H350

P

Muta. 1B

H340

Dgr

H340

STOT RE 1

H372 (central nervous system)

H372 (central nervous system)

Asp. Tox. 1

H304

H304

649-345-00-4

stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-3

8052-41-3

Carc. 1B

H350

GHS08

H350

P

Muta. 1B

H340

Dgr

H340

STOT RE 1

H372 (central nervous system)

H372 (central nervous system)

Asp. Tox. 1

H304

H304

649-405-00-X

solvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-7

64742-88-7

STOT RE 1

H372 (central nervous system)

GHS08

H372 (central nervous system)

Asp. Tox. 1

H304

Dgr

H304

---

ANNEX III

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits,
  M — Factors | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) |
| 031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. 1B | H350 | GHS08 | H350 | | | |
| STOT RE 1 | H372 (respiratory and haematopoietic systems) | Dgr | H372 (respiratory and haematopoietic systems) |
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H336 | GHS08
  Dgr | H336 |
| 606-145-00-1 | sulcotrione (ISO);
  2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione | | 99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | | M = 1
  M = 10 | |
| STOT RE 2 | H373 (kidneys) | GHS07 | H373 (kidneys) |
| Skin Sens. 1A | H317 | GHS09 | H317 |
| Aquatic Acute 1 | H400 | Wng | |
| Aquatic Chronic 1 | H410 | | H410 |
| 607-699-00-7 | bifenthrin (ISO);
  (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate | | 82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | | M = 10 000
  M = 100 000 | |
| Acute Tox. 3 | H331 | GHS08 | H331 |
| Acute Tox. 2 | H300 | GHS09 | H300 |
| STOT RE 1 | H372 (nervous system) | Dgr | H372 (nervous system) |
| Skin Sens. 1B | H317 | | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 607-700-00-0 | indoxacarb (ISO);
  methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] | | 173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | | M = 1
  M = 1 | |
| Acute Tox. 4 | H332 | GHS08 | H332 |
| STOT RE 1 | H372 (blood, nervous system, heart) | GHS09 | H372 (blood, nervous system, heart) |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
  methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] | 144171-61-9 [2] | | | | |
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | | |
| 607-703-00-7 | ammoniumpentadeca- fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D |
| Lact. | H362 | GHS05 | H362 |
| Acute Tox. 4 | H332 | Dgr | H332 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 (liver) | | H372 (liver) |
| Eye Dam.1 | H318 | | H318 |
| 607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | | |
| Repr. 1B | H360D | GHS07 | H360D |
| Lact. | H362 | GHS05 | H362 |
| Acute Tox. 4 | H332 | Dgr | H332 |
| Acute Tox. 4 | H302 | | H302 |
| STOT RE 1 | H372 (liver) | | H372 (liver) |
| Eye Dam. 1 | H318 | | H318 |
| 612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | | M = 10
  M = 10 | |
| STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system) |
| Skin Irrit. 2 | H315 | GHS09 | H315 |
| Eye Dam. 1 | H318 | Dgr | H318 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H335 | GHS08 | H335 |
| STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system) |
| Skin Corr. 1B | H314 | Dgr | H314 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | | M = 10
  M = 10 | |
| STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS05 | H373 (gastro-intestinal tract, liver, immune system) |
| Skin Irrit. 2 | H315 | GHS09 | H315 |
| Eye Dam. 1 | H318 | Dgr | H318 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT SE 3 | H335 | GHS08 | H335 |
| STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system) |
| Skin Corr. 1B | H314 | Dgr | H314 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | | M = 10
  M = 10 | |
| Asp. Tox. 1 | H304 | GHS07 | H304 |
| STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system) |
| Skin Corr. 1B | H314 | GHS09 | H314 |
| Aquatic Acute 1 | H400 | Dgr | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-206-00-4 | flufenoxuron (ISO);
  1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea | 417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | | M = 10 000
  M = 10 000 | |
| Aquatic Acute 1 | H400 | Wng | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. 2 | H351 | GHS05 | H351 | | M = 10
  M = 10 | |
| Acute Tox. 4 | H302 | GHS07 | H302 |
| STOT RE 1 | H372 (respiratory tract) (inhalation) | GHS08 | H372 (respiratory tract) (inhalation) |
| Eye Dam. 1 | H318 | GHS09 | H318 |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-208-00-5 | N-ethyl-2-pyrrolidone;
  1-ethylpyrrolidin-2-one | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 616-209-00-0 | amidosulfuron (ISO);
  3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea | 407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | | | M = 100
  M = 100 | |
| Aquatic Chronic 1 | H410 | Wng | H410 |
| 616-210-00-6 | tebufenpyrad (ISO);
  N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide | | 119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | | M = 10
  M = 10 | |
| Acute Tox. 4 | H332 | GHS08 | H332 |
| STOT RE 2 | H373 (gastro-intestinal tract) (Oral) | GHS09 | H373 (gastro-intestinal tract) (Oral) |
| Skin Sens. 1B | H317 | Dgr | H317 |
| Aquatic Acute 1 | H400 | | |
| Aquatic Chronic 1 | H410 | | H410 |
| 616-211-00-1 | proquinazid (ISO);
  6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one | | 189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | | M = 1
  M = 10 | |
| Aquatic Acute 1 | H400 | GHS09 | |
| Aquatic Chronic 1 | H410 | Wng | H410 |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Specific Conc. Limits,

M — Factors

Notes

Hazard Class and Category Code(s)

Hazard statement Code(s)

Pictogram, Signal Word Code(s)

Hazard statement Code(s)

Suppl. Hazard statement Code(s)

031-001-00-4

gallium arsenide

215-114-8

1303-00-0

Carc. 1B

H350

GHS08

H350

STOT RE 1

H372 (respiratory and haematopoietic systems)

Dgr

H372 (respiratory and haematopoietic systems)

050-025-00-6

trichloromethylstannane

213-608-8

993-16-8

Repr. 2

H361d

GHS08

Wng

H361d

050-026-00-1

2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-828-5

57583-34-3

Repr. 2

H361d

GHS08

Wng

H361d

050-027-00-7

2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

239-622-4

15571-58-1

Repr. 1B

H360D

GHS08

Dgr

H360D

601-087-00-3

2,4,4-trimethylpentene

246-690-9

25167-70-8

Flam. Liq. 2

H225

GHS02

H225

D

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H336

GHS08

Dgr

H336

606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

Repr. 2

H361d

GHS08

H361d

M = 1

M = 10

STOT RE 2

H373 (kidneys)

GHS07

H373 (kidneys)

Skin Sens. 1A

H317

GHS09

H317

Aquatic Acute 1

H400

Wng

Aquatic Chronic 1

H410

H410

607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

Carc. 2

H351

GHS06

H351

M = 10 000

M = 100 000

Acute Tox. 3

H331

GHS08

H331

Acute Tox. 2

H300

GHS09

H300

STOT RE 1

H372 (nervous system)

Dgr

H372 (nervous system)

Skin Sens. 1B

H317

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1]

Acute Tox. 3

H301

GHS06

H301

M = 1

M = 1

Acute Tox. 4

H332

GHS08

H332

STOT RE 1

H372 (blood, nervous system, heart)

GHS09

H372 (blood, nervous system, heart)

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2]

607-702-00-1

dihexyl phthalate

201-559-5

84-75-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-703-00-7

ammoniumpentadeca- fluorooctanoate

223-320-4

3825-26-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Dgr

H332

Acute Tox. 4

H302

H302

STOT RE 1

H372 (liver)

H372 (liver)

Eye Dam.1

H318

H318

607-704-00-2

perfluorooctanoic acid

206-397-9

335-67-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Dgr

H332

Acute Tox. 4

H302

H302

STOT RE 1

H372 (liver)

H372 (liver)

Eye Dam. 1

H318

H318

612-282-00-8

octadecylamine

204-695-3

124-30-1

Asp. Tox. 1

H304

GHS05

H304

M = 10

M = 10

STOT RE 2

H373 (gastro-intestinal tract, liver, immune system)

GHS08

H373 (gastro-intestinal tract, liver, immune system)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Dgr

H318

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (gastro-intestinal tract, liver, immune system)

GHS09

H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B

H314

Dgr

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-284-00-9

amines, hydrogenated tallow alkyl

262-976-6

61788-45-2

Asp Tox. 1

H304

GHS08

H304

M = 10

M = 10

STOT RE 2

H373 (gastro-intestinal tract, liver, immune system)

GHS05

H373 (gastro-intestinal tract, liver, immune system)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Dgr

H318

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-285-00-4

amines, coco alkyl

262-977-1

61788-46-3

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (gastro-intestinal tract, liver, immune system)

GHS09

H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B

H314

Dgr

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

612-286-00-X

amines, tallow alkyl

263-125-1

61790-33-8

Acute Tox. 4

H302

GHS05

H302

M = 10

M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT RE 2

H373 (gastro-intestinal tract, liver, immune system)

GHS08

H373 (gastro-intestinal tract, liver, immune system)

Skin Corr. 1B

H314

GHS09

H314

Aquatic Acute 1

H400

Dgr

Aquatic Chronic 1

H410

H410

616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3

101463-69-8

Lact.

H362

GHS09

H362

M = 10 000

M = 10 000

Aquatic Acute 1

H400

Wng

Aquatic Chronic 1

H410

H410

616-207-00-X

polyhexamethylene biguanide hydrochloride

27083-27-8 or 32289-58-0

Carc. 2

H351

GHS05

H351

M = 10

M = 10

Acute Tox. 4

H302

GHS07

H302

STOT RE 1

H372 (respiratory tract) (inhalation)

GHS08

H372 (respiratory tract) (inhalation)

Eye Dam. 1

H318

GHS09

H318

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-6

2687-91-4

Repr. 1B

H360D

GHS08

Dgr

H360D

616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

Aquatic Acute 1

H400

GHS09

M = 100

M = 100

Aquatic Chronic 1

H410

Wng

H410

616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide

119168-77-3

Acute Tox. 3

H301

GHS06

H301

M = 10

M = 10

Acute Tox. 4

H332

GHS08

H332

STOT RE 2

H373 (gastro-intestinal tract) (Oral)

GHS09

H373 (gastro-intestinal tract) (Oral)

Skin Sens. 1B

H317

Dgr

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

H410

616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

Carc. 2

H351

GHS08

H351

M = 1

M = 10

Aquatic Acute 1

H400

GHS09

Aquatic Chronic 1

H410

Wng

H410

---

ANNEX IV

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | F; R15/29
  T+; R26/28
  Xn; R21
  R32
  N; R50 | F; T+; N
  R: 15/29-21-26/28-32-50
  S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 | N; R50: C ≥ 0,25 % | |
| 015-005-00-3 | magnesium phosphide;
  trimagnesium diphosphide | 235-023-7 | 12057-74-8 | F; R15/29
  T+; R26/28
  Xn; R21
  R32
  N; R50 | F; T+; N
  R: 15/29-21-26/28-32-50
  S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 | N; R50: C ≥ 0,25 % | |
| 015-123-00-5 | fenamiphos (ISO);
  ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | T+; R26/28
  T; R24
  Xi; R36
  N; R50-53 | T+; N
  R: 24-26/28-36-50/53
  S: (1/2-)23-26-28-35-36/37-45-60-61 | N; R50-53: C ≥ 0,25 %
  N; R51-53: 0,025 % ≤ C < 0,25 %
  R52-53: 0,0025 % ≤ C < 0,025 % | |
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | R53 | R: 53
  S: 61 | | |
| 602-006-00-4 | chloroform;
  trichloromethane | 200-663-8 | 67-66-3 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  Xn; R20/22-48/20
  Xi; R36/38 | Xn
  R: 20/22-36/38-40-48/20-63
  S: (2-)36/37 | | |
| 603-097-00-3 | 1,1′,1′′-nitrilotripropan-2-ol;
  triisopropanolamine | 204-528-4 | 122-20-3 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 605-008-00-3 | acrolein;
  prop-2-enal;
  acrylaldehyde | 203-453-4 | 107-02-8 | F; R11
  T+; R26/28
  T; R24
  C; R34
  N; R50 | F; T+; N
  R: 11-24-26/28-34-50
  S: (1/2-)23-26-28-36/37/39-45-61 | C; R34: C ≥ 0,1 %
  N; R50: C ≥ 0,25 % | D |
| 607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | F; R11
  Carc. Cat. 3; R40
  Xn; R20
  Xi; R37 | F; Xn
  R: 11-20-37-40
  S: 9-16-33-36/37 | | D |
| 607-613-00-8 | reaction mass of: | succinic acid |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes

015-004-00-8

aluminium phosphide

244-088-0

20859-73-8

F; R15/29

T+; R26/28

Xn; R21

R32

N; R50

F; T+; N

R: 15/29-21-26/28-32-50

S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

N; R50: C ≥ 0,25 %

015-005-00-3

magnesium phosphide;

trimagnesium diphosphide

235-023-7

12057-74-8

F; R15/29

T+; R26/28

Xn; R21

R32

N; R50

F; T+; N

R: 15/29-21-26/28-32-50

S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

N; R50: C ≥ 0,25 %

015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-1

22224-92-6

T+; R26/28

T; R24

Xi; R36

N; R50-53

T+; N

R: 24-26/28-36-50/53

S: (1/2-)23-26-28-35-36/37-45-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

R53

R: 53

S: 61

602-006-00-4

chloroform;

trichloromethane

200-663-8

67-66-3

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20/22-48/20

Xi; R36/38

Xn

R: 20/22-36/38-40-48/20-63

S: (2-)36/37

603-097-00-3

1,1′,1′′-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4

122-20-3

Xi; R36

Xi

R: 36

S: (2-)26

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4

107-02-8

F; R11

T+; R26/28

T; R24

C; R34

N; R50

F; T+; N

R: 11-24-26/28-34-50

S: (1/2-)23-26-28-36/37/39-45-61

C; R34: C ≥ 0,1 %

N; R50: C ≥ 0,25 %

D

607-023-00-0

vinyl acetate

203-545-4

108-05-4

F; R11

Carc. Cat. 3; R40

Xn; R20

Xi; R37

F; Xn

R: 11-20-37-40

S: 9-16-33-36/37

D

607-613-00-8

reaction mass of:

succinic acid

| | monopersuccinic acid |
| --- | --- |

monopersuccinic acid

| | dipersuccinic acid |
| --- | --- |

dipersuccinic acid

| | monomethyl ester of succinic acid |
| --- | --- |

monomethyl ester of succinic acid

| | monomethyl ester of persuccinic acid |
| --- | --- |

monomethyl ester of persuccinic acid

| | dimethyl succinate |
| --- | --- |

dimethyl succinate

| | glutaric acid |
| --- | --- |

glutaric acid

| | monoperglutaric acid |
| --- | --- |

monoperglutaric acid

| | diperglutaric acid |
| --- | --- |

diperglutaric acid

| | monomethyl ester of glutaric acid |
| --- | --- |

monomethyl ester of glutaric acid

| | monomethyl ester of perglutaric acid |
| --- | --- |

monomethyl ester of perglutaric acid

| | dimethyl glutarate |
| --- | --- |

dimethyl glutarate

| | adipic acid |
| --- | --- |

adipic acid

| | monoperadipic acid |
| --- | --- |

monoperadipic acid

| | diperadipic acid |
| --- | --- |

diperadipic acid

| | monomethyl ester of adipic acid |
| --- | --- |

monomethyl ester of adipic acid

| | monomethyl ester of peradipic acid |
| --- | --- |

monomethyl ester of peradipic acid

| | dimethyl adipate |
| --- | --- |

dimethyl adipate

| | hydrogen peroxide |
| --- | --- |

hydrogen peroxide

| | methanol |
| --- | --- |

methanol

| | water |
| --- | --- |

water

432-790-1

C; R34

Xn; R20/21/22-68/20/21/22

C

R: 20/21/22-34-68/20/21/22

S: (1/2-)26-28-36/37/39-45

609-003-00-7

nitrobenzene

202-716-0

98-95-3

Carc. Cat. 3; R40

Repr. Cat. 2; R60

T; R23/24/25-48/23/24/25

R52-53

T

R: 23/24/25-48/23/24/25-40-60-52/53

S: 45-53

612-120-00-6

aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline

277-704-1

74070-46-5

Carc. Cat. 3; R40

R43

N; R50-53

Xn; N

R: 40-43-50/53

S: (2-)36/37-60-61

R43: C ≥ 0,1 %

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

613-175-00-9

epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2

133855-98-8

Carc. Cat. 3; R40

Repr. Cat. 2; R61

Repr. Cat. 3; R62

N; R51-53

T; N

R: 61-40-62-51/53

S: 45-53-61

616-200-00-1

reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)

432-430-3

R53

R: 53

S: 61

648-055-00-5

pitch, coal tar, high-temp.;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-2

65996-93-2

Carc. Cat. 1; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

N; R50-53

T; N

R: 45-46-60-61-50/53

S: 45-53-60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C <

0,025  %

R52-53: 0,00025 % ≤ C <

0,0025  %

649-330-00-2

naphtha (petroleum), hydrodesulphurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-4

64742-82-1

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/20-65

T

R: 45-46-48/20-65

S: 45-53

P

649-345-00-4

stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-3

8052-41-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/20-65

T

R: 45-46-48/20-65

S: 45-53

P

649-405-00-X

solvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-7

64742-88-7

Xn; R48/20-65

Xn

R: 48/20-65

S: (2-)23-24-62

---

ANNEX V

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. Cat. 2; R45
  T; R48/23 | T
  R: 45-48/23
  S: 45-53 | | E |
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. Cat. 3; R63 | Xn
  R: 63
  S: (2-)22-36/37 | | |
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. Cat. 3; R63 | Xn
  R: 63
  S: (2-)22-36/37 | | |
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. Cat. 2; R61 | T
  R: 61
  S: 45-53 | | |
| 601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | F; R11
  Xn; R65
  R67 | F; Xn
  R: 11-65-67
  S: 9-16-33-62 | | D |
| 606-145-00-1 | sulcotrione (ISO);
  2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione | | 99105-77-8 | Repr. Cat. 3; R63
  Xn; R48/22
  R43
  N; R50-53 | Xn; N
  R: 43-48/22-63-50/53
  S: (2-)22-36/37-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C< 2,5 %
  R43: C ≥ 0,1 % | |
| 607-699-00-7 | bifenthrin (ISO);
  (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate | | 82657-04-3 | Carc. Cat 3; R40
  T; R23/25
  Xn; R48/22
  R43
  N; R50-53 | T; N
  R: 23/25-40-43-48/22-50/53
  S: (1/2-)23-24-36/37-38- 45-60-61 | N; R50-53: C ≥ 0,0025 %
  N; R51-53: 0,00025 % ≤ C< 0,0025 %
  R52-53: 0,000025 % ≤ C < 0,00025 % | |
| 607-700-00-0 | indoxacarb (ISO);
  methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate | | 173584-44-6 | T; R25-48/25
  Xn; R20
  R43
  N; R50-53 | T; N
  R: 20-25-43-48/25-50/53
  S: (1/2-)24-37-45-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 % | |
| 607-701-00-6 | reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
  methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate | | 144171-61-9 | T; R48/25
  Xn; R20/22
  R43
  N; R50-53 | T; N
  R: 20/22-43-48/25-50/53
  S: (1/2-)24-37-45-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 % | |
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. Cat. 2; R60-61 | T
  R: 60-61
  S: 45-53 | | |
| 607-703-00-7 | ammoniumpentade-cafluorooctanoate | 223-320-4 | 3825-26-1 | Carc. Cat. 3; R40
  Repr. Cat. 2; R61
  R64
  T; R48/23
  Xn; R20/22-48/21/22
  Xi; R41 | T
  R: 61-20/22-40-41- 48/23-48/21/22-64
  S: 45-53 | | |
| 607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. Cat. 3; R40
  Repr. Cat. 2; R61
  R64
  T; R48/23
  Xn; R20/22-48/21/22
  Xi; R41 | T
  R: 61-20/22-40-41-48/23-48/21/22-64
  S: 45-53 | | |
| 612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Xn; R48/22-65
  Xi; R38-41
  N; R50-53 | Xn; N
  R: 38-41-48/22-65-50/53
  S: (2-)26-36/37/39-60-61-62 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Xn; R22-48/22-65
  C; R34
  N; R50-53 | C; N
  R: 22-34-48/22-65-50/53
  S: (1/2-)23-26-36/37/39-45-60-61-62 | C; R34: C ≥ 10 %
  Xi; R36/37/38: 5 % ≤ C < 10 %
  N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Xn; R48/22-65
  Xi; R38-41
  N; R50-53 | Xn; N
  R: 38-41-48/22-65-50/53
  S: (2-)26-36/37/39-60-61-62 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Xn; R22-48/22-65
  C; R35
  N; R50-53 | C; N
  R: 22-35-48/22-65-50/53
  S: (1/2-)23-26-36/37/39-45-60-61-62 | C; R35: C ≥ 10 %
  C; R34: 5 % ≤ C < 10 %
  Xi; R36/37/38: 1 % ≤ C < 5 %
  N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Xn; R22-48/22-65
  C; R35
  N; 50-53 | C; N
  R: 22-35-48/22-65-50/53
  S: (1/2-)26-36/37/39-45-60-61-62 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 616-206-00-4 | flufenoxuron (ISO);
  1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea | 417-680-3 | 101463-69-8 | R64
  R33
  N; R50-53 | N
  R: 33-64-50/53
  S: (2-)22-36/37-46-60-61 | N; R50-53 C ≥ 0,0025 %
  N; R51-53 0,00025 % ≤ C < 0,0025 %
  R52-53 0,000025 % ≤ C < 0,00025 % | |
| 616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. Cat 3; R40
  Xn; R22
  T; R48/23
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 22-40-41-43-48/23-50/53
  S: (1/2-)22-36/37/39-45-60-61 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 616-208-00-5 | N-ethyl-2-pyrrolidone;
  1-ethylpyrrolidin-2-one | 220-250-6 | 2687-91-4 | Repr. Cat. 2; R61 | T
  R: 61
  S: 45-53 | | |
| 616-209-00-0 | amidosulfuron (ISO);
  3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea | 407-380-0 | 120923-37-7 | N; R50-53 | N
  R: 50/53
  S: 60-61 | N; R50-53: C ≥ 0,25 %
  N; R51-53: 0,025 % ≤ C < 0,25 %
  R52-53: 0,0025 % ≤ C < 0,025 % | |
| 616-210-00-6 | tebufenpyrad (ISO);
  N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-carboxamide | | 119168-77-3 | Xn; R20/22
  R43
  N; R50-53 | Xn; N
  R: 20/22-43-50/53
  S: (2-)24-37-46-60-61 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 616-211-00-1 | proquinazid (ISO);
  6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one | | 189278-12-4 | Carc. Cat. 3; R40
  N; R50-53 | Xn; N
  R: 40-50/53
  S: (2-)36/37-46-60-61 | | |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes

031-001-00-4

gallium arsenide

215-114-8

1303-00-0

Carc. Cat. 2; R45

T; R48/23

T

R: 45-48/23

S: 45-53

E

050-025-00-6

trichloromethylstannane

213-608-8

993-16-8

Repr. Cat. 3; R63

Xn

R: 63

S: (2-)22-36/37

050-026-00-1

2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-828-5

57583-34-3

Repr. Cat. 3; R63

Xn

R: 63

S: (2-)22-36/37

050-027-00-7

2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

239-622-4

15571-58-1

Repr. Cat. 2; R61

T

R: 61

S: 45-53

601-087-00-3

2,4,4-trimethylpentene

246-690-9

25167-70-8

F; R11

Xn; R65

R67

F; Xn

R: 11-65-67

S: 9-16-33-62

D

606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

Repr. Cat. 3; R63

Xn; R48/22

R43

N; R50-53

Xn; N

R: 43-48/22-63-50/53

S: (2-)22-36/37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C< 2,5 %

R43: C ≥ 0,1 %

607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

Carc. Cat 3; R40

T; R23/25

Xn; R48/22

R43

N; R50-53

T; N

R: 23/25-40-43-48/22-50/53

S: (1/2-)23-24-36/37-38- 45-60-61

N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C< 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %

607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate

173584-44-6

T; R25-48/25

Xn; R20

R43

N; R50-53

T; N

R: 20-25-43-48/25-50/53

S: (1/2-)24-37-45-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-701-00-6

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate

144171-61-9

T; R48/25

Xn; R20/22

R43

N; R50-53

T; N

R: 20/22-43-48/25-50/53

S: (1/2-)24-37-45-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-702-00-1

dihexyl phthalate

201-559-5

84-75-3

Repr. Cat. 2; R60-61

T

R: 60-61

S: 45-53

607-703-00-7

ammoniumpentade-cafluorooctanoate

223-320-4

3825-26-1

Carc. Cat. 3; R40

Repr. Cat. 2; R61

R64

T; R48/23

Xn; R20/22-48/21/22

Xi; R41

T

R: 61-20/22-40-41- 48/23-48/21/22-64

S: 45-53

607-704-00-2

perfluorooctanoic acid

206-397-9

335-67-1

Carc. Cat. 3; R40

Repr. Cat. 2; R61

R64

T; R48/23

Xn; R20/22-48/21/22

Xi; R41

T

R: 61-20/22-40-41-48/23-48/21/22-64

S: 45-53

612-282-00-8

octadecylamine

204-695-3

124-30-1

Xn; R48/22-65

Xi; R38-41

N; R50-53

Xn; N

R: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Xn; R22-48/22-65

C; R34

N; R50-53

C; N

R: 22-34-48/22-65-50/53

S: (1/2-)23-26-36/37/39-45-60-61-62

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-284-00-9

amines, hydrogenated tallow alkyl

262-976-6

61788-45-2

Xn; R48/22-65

Xi; R38-41

N; R50-53

Xn; N

R: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-285-00-4

amines, coco alkyl

262-977-1

61788-46-3

Xn; R22-48/22-65

C; R35

N; R50-53

C; N

R: 22-35-48/22-65-50/53

S: (1/2-)23-26-36/37/39-45-60-61-62

C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-286-00-X

amines, tallow alkyl

263-125-1

61790-33-8

Xn; R22-48/22-65

C; R35

N; 50-53

C; N

R: 22-35-48/22-65-50/53

S: (1/2-)26-36/37/39-45-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3

101463-69-8

R64

R33

N; R50-53

N

R: 33-64-50/53

S: (2-)22-36/37-46-60-61

N; R50-53 C ≥ 0,0025 %

N; R51-53 0,00025 % ≤ C < 0,0025 %

R52-53 0,000025 % ≤ C < 0,00025 %

616-207-00-X

polyhexamethylene biguanide hydrochloride

27083-27-8 or 32289-58-0

Carc. Cat 3; R40

Xn; R22

T; R48/23

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/23-50/53

S: (1/2-)22-36/37/39-45-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-6

2687-91-4

Repr. Cat. 2; R61

T

R: 61

S: 45-53

616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

N; R50-53

N

R: 50/53

S: 60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-carboxamide

119168-77-3

Xn; R20/22

R43

N; R50-53

Xn; N

R: 20/22-43-50/53

S: (2-)24-37-46-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

---